Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin and Temozolomide for Unresectable Glioblastoma
NCT00612339Phase 2Completed
- Sponsor
- Duke University
- Start
- Aug 2007
- Primary completion
- May 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in glioblastoma (GBM), Gliosarcoma (GS), sponsored by Duke University. Started Aug 2007; status: completed.
02
Drugs
bevacizumab
03
Conditions
glioblastoma (GBM)Gliosarcoma (GS)
Beyond the preview
Go deeper on NCT00612339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00612339.